The clinical results of SCO-267 was presented at the Virtual 81st Scientific Sessions - American Diabetes Association: First report on the clinical data of a GPR40 full agonist in the phase 1 trial
June 28, 2021
June 28, 2021
June 18, 2021
June 8, 2021
June 1, 2021
May 6, 2021
April 27, 2021
March 30, 2021
March 2, 2021
February 18, 2021
October 30, 2025
Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One™ solid-phase ...
October 29, 2025
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible EazeBio today announced a ...
October 9, 2025
Alithea Genomics, a leader in next-generation transcriptomic solutions, today announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225